联系方式

Ross McNaughton

合伙人

Read More
联系方式

Ross McNaughton

合伙人

Read More

2021年1月15日

Advising Oxbotica in $47 million Series B investment

On 6 January 2021, Oxbotica, a global leader in autonomous vehicle software, announced the completion of a $47 million Series B investment with partners across the globe led by bp ventures. 

Other investors in the round include BGF, Halma, HostPlus, IP Group, Tencent, Venture Science, and funds advised by Doxa Partners. With financial and strategic investors in Australia, China, the UK, and the US, Oxbotica is placed at the center of a global autonomy ecosystem. 

The funding will accelerate Oxbotica's commercial deployment of its world-class autonomy software platform across multiple industries and key markets. The news is an endorsement of Oxbotica's go-to-market strategy, deploying its autonomy software in industrial use cases in advance of rolling out in urban passenger transportation applications in the future.

In collaboration with Wilson Sonsini, Taylor Wessing supported on UK aspects of the transaction with partner Ross McNaughton, Matt Harrison and Becca Gaunt working with Mike Labriola, Daniel Glazer, Jose Campos, Diviya Padman, and Betty Rosenbaum from Wilson Sonsini representing Oxbotica in the transaction.

For more information, please see Oxbotica's press release.

Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

公司/并购与资本市场

Advising on Mission Zero Technologies on its £21.8 million Series A funding

2024年3月20日

作者 Ross McNaughton 以及 Oli Denne

点击此处了解更多
公司/并购与资本市场

Nuclera raises additional capital for eProtein™ desktop bioprinter to close Series B funding at $58 million

2022年7月14日

作者

点击此处了解更多
公司/并购与资本市场

Advising New Science Ventures as lead investor on Paragraf's $60 million Series B funding round

2022年3月4日

作者 Ross McNaughton 以及 Adrian Toutoungi

点击此处了解更多